This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.

Direct FDA to research medical uses of LSD and Ibogaine to cure Heroin addiction, potentially moving them to Schedule II

Created by K.R. on October 31, 2011

Ibogaine, a naturally-occurring hallucinogen, has been shown to cure heroin and opiate addictions. It is currently being used in Canada and Mexico to treat these addictions, supposedly with high success rates. The US FDA currently only allows methadone, a weakened form of heroin, as a treatment method. Ibogaine's treatment is a single dose, creating an extended (several-days-long) 'trip' which cures both the physical addiction by affecting brain chemistry, and psychosocial behavioral addiction by forcing reflection on what led to the addiction in the first place. Likewise, LSD has had some indications of success in treatment of various disorders. These drugs should be treated as Schedule II, meaning dangerous and possibly addictive, but having established medically beneficial usage.

Foreign Policy
Health Care
Government & Regulatory Reform
Return to top